Impact of smoking on biologicals treatment response in patients from the German Severe Asthma (GAN) Registry
S Stoshikj, L Biener, J Brugger, C Krall, K Milger… - 2023 - Eur Respiratory Soc
Clinical studies in asthma usually exclude smokers or ex-smokers with >10 pack-years (PY).
Thus the efficiency of biological (BT) in severe smoking asthmatics is unknown. We …
Thus the efficiency of biological (BT) in severe smoking asthmatics is unknown. We …
Real-world experience on the use of mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)
S Korn, K Milger, D Skowasch, C Schulz… - Journal of Asthma …, 2023 - Taylor & Francis
Purpose The German Asthma Net (GAN) operates a Severe Asthma Registry that provides
an overview of the clinical presentation and management of patients with severe asthma. …
an overview of the clinical presentation and management of patients with severe asthma. …
Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments
A Tufman, A Gallace, K Kahnert, K Milger, RM Huber - 2016 - Eur Respiratory Soc
Background: Lung cancer patients often have impaired lung function, which limits treatment
options and impairs quality of life. Also, treatment may cause further deteriorations in lung …
options and impairs quality of life. Also, treatment may cause further deteriorations in lung …
Determinanten des Verlaufs bei Patienten mit chronisch-obstruktiver Lungenerkrankung (COPD) sowie der Symptome in Bezug auf Lungenfunktion, kardiale Funktion …
BA Mayerhofer - 2023 - edoc.ub.uni-muenchen.de
Die chronisch-obstruktive Lungenerkrankung (COPD) ist eine weit verbreitete Erkrankung
mit einer hohen Prävalenz und gehört zu den sogenannten Volkskrankheiten. Zur Diagnose …
mit einer hohen Prävalenz und gehört zu den sogenannten Volkskrankheiten. Zur Diagnose …
Oxygenated hemoglobin predicts outcome in patients with chronic lung allograft dysfunction
K Kahnert, FC Trudzinski, C Berger, D Munker, K Milger… - Respiration, 2022 - karger.com
Background: Long-term outcome of lung transplantation (LTx) recipients is limited by chronic
lung allograft dysfunction (CLAD). In this setting of new onset respiratory failure, the amount …
lung allograft dysfunction (CLAD). In this setting of new onset respiratory failure, the amount …
Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer
…, T Duell, D Kauffmann-Guerrero, K Milger… - OncoTargets and …, 2017 - Taylor & Francis
Background Tyrosine kinase inhibitors (TKIs) have improved response rates in some
patients with non-small cell lung cancer (NSCLC), and testing for EGFR mutation and ALK …
patients with non-small cell lung cancer (NSCLC), and testing for EGFR mutation and ALK …
[PDF][PDF] DIRK BUSCH (MUNICH)
DH Busch - IMMUNE & CELLULAR THERAPIES: FOCUS ON …, 2022 - boa.unimib.it
Effective antigen-specific T cell immune responses are usually characterized by the initial
recruitment of polyclonal populations from the naïve compartment, consisting of a repertoire of …
recruitment of polyclonal populations from the naïve compartment, consisting of a repertoire of …
Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer
…, F Manapov, K Milger… - Strahlentherapie …, 2017 - search.proquest.com
Objective The TNM 8 lung cancer staging system reclassifies patients with a solitary
extrathoracic metastasis as M1b and two or more extrathoracic metastases as M1c. This study …
extrathoracic metastasis as M1b and two or more extrathoracic metastases as M1c. This study …
Klinische Relevanz der M1b-und M1c-Deskriptoren der neuen TNM-8-Klassifikation des Lungenkarzinoms
…, D Kauffmann-Guerrero, F Manapov, K Milger… - Strahlentherapie und …, 2017 - Springer
Objective The TNM 8 lung cancer staging system reclassifies patients with a solitary
extrathoracic metastasis as M1b and two or more extrathoracic metastases as M1c. This study …
extrathoracic metastasis as M1b and two or more extrathoracic metastases as M1c. This study …
P1. 06-035 Frequency and Clinical Relevance of EGFR-Mutations and EML4-ALK-Translocations in Octagenarians with NSCLC: Topic: Advanced General
…, S Hasmann, D Kauffmann-Guerrero, K Milger… - Journal of Thoracic …, 2017 - jto.org
Background Novel therapies targeting genetic alterations have improved response rates
and overall survival for some patients with NSCLC; however, only a minority of Caucasian …
and overall survival for some patients with NSCLC; however, only a minority of Caucasian …